Michael Rosenblatt's Net Worth

$5.79 Million

Estimate Recalculated Jun 4, 2024 02:04PM EST

Who is Michael Rosenblatt?

Michael Rosenblatt has an estimated net worth of $5.79 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., Azenta, Inc., Rubius Therapeutics, Inc., and Axcella Health Inc..

SEC CIK

Michael Rosenblatt's CIK is 0001478797

Past Insider Trading and Trends

2010 was Michael Rosenblatt's most active year for acquiring shares with 4 total transactions. Michael Rosenblatt's most active month to acquire stocks was the month of April. 2013 was Michael Rosenblatt's most active year for disposing of shares, totalling 4 transactions. Michael Rosenblatt's most active month to dispose stocks was the month of April. 2016 saw Michael Rosenblatt paying a total of $392,858.26 for 58,672 shares, this is the most they've acquired in one year. In 2013 Michael Rosenblatt cashed out on 27,418 shares for a total of $1,159,868.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merck & Co., Inc. (MRK) Snapshot price: $127.55

Exec V-P & Chief Med Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 10
Form 4
+23.17%
7.74K
$50.77
$392,858.26
41.13K
Feb 22
Form 4
+5.98%
1.84K
$59.86
-$118,522.80
32.55K
May 1 - May 2
Form 4
+19.63%
5K
$58.30
$291,558.30
30.48K
Feb 23
Form 4
0
0
May 9
Form 4
+10.19%
2.3K
$58.22
-$104,737.78
24.92K
May 4
Form 4
+27.99%
4.91K
$56.18
$275,675.26
22.44K
Feb 24
Form 4
+14.45%
2.16K
$44.98
-$104,488.54
17.07K
May 6 - May 7
Form 4
+57.46%
5.39K
$42.52
$229,267.84
14.78K
Feb 25
Form 4
9.38K
$41.42
-$232,614.72
9.38K
Feb 19
Form 4
0
0
May 2
Form 4
0
0
May 4
Form 4
0
0
May 7
Form 4
0
0
Feb 19
Form 3
0
0
No matching records found

Azenta, Inc. (AZTA) Snapshot price: $65.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+23.31%
2.46K
$65.93
$162,517.45
13.04K
Feb 12
Form 4
+51.69%
3.6K
10.58K
Feb 13
Form 4
+38.05%
1.92K
6.97K
Feb 11
Form 4
-35.92%
-2.83K
$114.13
-$323,102.03
5.05K
Nov 12
Form 4
-18.25%
-1.76K
$90.00
-$158,400.00
7.88K
May 13
Form 4
+22.33%
1.76K
9.64K
Feb 5
Form 4
+56.05%
2.83K
7.88K
Feb 11
Form 4
+396.17%
4.03K
5.05K
Feb 8
Form 4
1.02K
1.02K
Sep 7
Form 3
0
0
No matching records found

Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.057

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 12
Form 4
0
0
May 12
Form 4
0
0
May 21
Form 4
0
0
May 23
Form 4
0
0
Jul 17
Form 3
0
0
No matching records found

Axcella Health Inc. (AXLA) Snapshot price: $0.4009

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 19
Form 3
0
0
No matching records found